Plain-English translation of NCT07002866 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether a combination approach can help young women in Uganda access and stay on PrEP (a daily medication that prevents HIV infection). The program combines HIV education classes, support from other women who are already taking the medication, and help with financial barriers like transportation and food costs. Researchers want to see which combination of supports works best.
Young women in Uganda face much higher rates of HIV than young men, and traditional prevention methods don't always work because they depend on male partners. This medication is very effective, but many young women don't use it because of cost, lack of information, stigma, and not knowing where to get it. This study is trying to find ways to remove those barriers.
You likely qualify if…
You likely don't qualify if…
You will be randomly placed into one of three groups. All groups will attend 5 education sessions on HIV and the prevention medication led by a community healthcare worker. Depending on your group, you may also meet with peer supporters (other women taking the medication) at least 8 times to talk about how to access and use the medication, or you may receive help opening a savings account and taking financial literacy classes. The study lasts several months and involves sessions at your local health sites.
AI-generated summary from trial data · Jun 17, 2026 · Not medical advice
United States
Uganda